Sanai Health Industry Group Full Year 2023 Earnings: EPS: CN¥0.006 (vs CN¥0.01 in FY 2022)
Sanai Health Industry Group (HKG:1889) Full Year 2023 Results
Key Financial Results
- Revenue: CN¥122.1m (down 31% from FY 2022).
- Net income: CN¥18.6m (down 36% from FY 2022).
- Profit margin: 15% (down from 17% in FY 2022). The decrease in margin was driven by lower revenue.
- EPS: CN¥0.006 (down from CN¥0.01 in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Sanai Health Industry Group shares are down 11% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Sanai Health Industry Group has 2 warning signs we think you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:1889
Sanai Health Industry Group
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
Flawless balance sheet and good value.